{
  "id": 2493,
  "text": "244.Hubalewska, A., et al.Use of Tc99mnanocolloid for sentinel nodes identification in cervical cancer.Nucl Med Rev Cent East Eur 6, 127-130 (2003).245.Lambaudie, E., et al.Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 244.Hubalewska, A., et al.Use of Tc99mnanocolloid for sentinel nodes identification in cervical cancer.Nucl Med Rev Cent East Eur 6, 127-130 (2003).245.Lambaudie, E., et al.Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在早期宫颈癌的治疗中，使用 99m锝纳米胶体联合专利蓝染料注射进行腹腔镜活检时，可以识别的重要淋巴结是**前哨淋巴结**。前哨淋巴结是癌细胞从原发肿瘤扩散到淋巴系统时最先受累的淋巴结，定位和分析这些淋巴结有助于评估淋巴结中的癌细胞扩散情况，从而在早期阶段指导治疗决策并减少过度治疗风险。这种联合注射技术通过放射性示踪和染料着色提高了前哨淋巴结的识别率和精确度，并具有微创特点。",
  "query": "在早期宫颈癌的治疗中，使用 99m锝纳米胶体联合专利蓝染料注射进行腹腔镜活检时，可以识别哪些重要的淋巴结？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在早期宫颈癌的治疗中，使用 99m锝纳米胶体联合专利蓝染料注射进行腹腔镜活检时，可以识别哪些重要的淋巴结？\n\n<reference text>: 244.Hubalewska, A., et al.Use of Tc99mnanocolloid for sentinel nodes identification in cervical cancer.Nucl Med Rev Cent East Eur 6, 127-130 (2003).245.Lambaudie, E., et al.Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在早期宫颈癌的治疗中，使用 99m锝纳米胶体联合专利蓝染料注射进行腹腔镜活检时，可以识别的重要淋巴结是**前哨淋巴结**。前哨淋巴结是癌细胞从原发肿瘤扩散到淋巴系统时最先受累的淋巴结，定位和分析这些淋巴结有助于评估淋巴结中的癌细胞扩散情况，从而在早期阶段指导治疗决策并减少过度治疗风险。这种联合注射技术通过放射性示踪和染料着色提高了前哨淋巴结的识别率和精确度，并具有微创特点。"
}